HO-1 induction through Nrf2 nuclear translocation is a promising approach to treat various inflammatory diseases including atherosclerosis, inflammation induced insulin resistance, and dermatitis [41,42,43]. This evidence concerns the gene NFE2L2 and atherosclerosis.